ALPHA-GALACTOSYL CERAMIDE ANALOGS AND THEIR USE AS IMMUNOTHERAPIES, ADJUVANTS, AND INTIVIRAL, ANTIBACTERIAL, AND ANTICANCER AGENTS

The present disclosure relates to synthetic alpha-galactosyl ceramide (α-GalCer) analogs, and their use as immunotherapies. In one aspect. a method of activating a cytokine response in a subject includes administering an effective amount of a compound to a subject, wherein the subject has an adaptiv...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: YU ALICE, CHANG YA JEN, LIN YI LING, JAN JIA TSRONG, LIN KUN HSIEN, HUNG JUNG TUNG, CHENG Y. S. EDMOND, WONG CHI HUEY
Format: Patent
Sprache:eng ; kor
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator YU ALICE
CHANG YA JEN
LIN YI LING
JAN JIA TSRONG
LIN KUN HSIEN
HUNG JUNG TUNG
CHENG Y. S. EDMOND
WONG CHI HUEY
description The present disclosure relates to synthetic alpha-galactosyl ceramide (α-GalCer) analogs, and their use as immunotherapies. In one aspect. a method of activating a cytokine response in a subject includes administering an effective amount of a compound to a subject, wherein the subject has an adaptive immune system that includes a population of cells, the population including at least one lymphocyte and at least one antigen-presenting cell, and wherein the compound is represented by the structure of formula 1: or a pharmaceutically acceptable salt thereof; forming a complex between the compound and the antigen-presenting cell, wherein the formation of the complex results in the activation of a receptor on the lymphocyte; and activating the lymphocyte to produce the cytokine response.
format Patent
fullrecord <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_KR20110107317A</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>KR20110107317A</sourcerecordid><originalsourceid>FETCH-epo_espacenet_KR20110107317A3</originalsourceid><addsrcrecordid>eNqNjcEOgjAQRLl4MOo_NPEqCZUD56WtsFoKaQuJJ0JMPRklwS_wy13UD_A0Oy8zs8voBbopIS5Ag_C1O2smlIUKpWJgQNeFI5XMlwotax1Rx7CqWlMTstCgcjsG8th2YPx8UhiNxw4t6Nl6zGlZWfxa-UECDL1hUCgqraPFdbhNYfPTVbQ9KC_KOIyPPkzjcAn38OxPdp9wnvAkS3kG6X-pN5AbPQc</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>ALPHA-GALACTOSYL CERAMIDE ANALOGS AND THEIR USE AS IMMUNOTHERAPIES, ADJUVANTS, AND INTIVIRAL, ANTIBACTERIAL, AND ANTICANCER AGENTS</title><source>esp@cenet</source><creator>YU ALICE ; CHANG YA JEN ; LIN YI LING ; JAN JIA TSRONG ; LIN KUN HSIEN ; HUNG JUNG TUNG ; CHENG Y. S. EDMOND ; WONG CHI HUEY</creator><creatorcontrib>YU ALICE ; CHANG YA JEN ; LIN YI LING ; JAN JIA TSRONG ; LIN KUN HSIEN ; HUNG JUNG TUNG ; CHENG Y. S. EDMOND ; WONG CHI HUEY</creatorcontrib><description>The present disclosure relates to synthetic alpha-galactosyl ceramide (α-GalCer) analogs, and their use as immunotherapies. In one aspect. a method of activating a cytokine response in a subject includes administering an effective amount of a compound to a subject, wherein the subject has an adaptive immune system that includes a population of cells, the population including at least one lymphocyte and at least one antigen-presenting cell, and wherein the compound is represented by the structure of formula 1: or a pharmaceutically acceptable salt thereof; forming a complex between the compound and the antigen-presenting cell, wherein the formation of the complex results in the activation of a receptor on the lymphocyte; and activating the lymphocyte to produce the cytokine response.</description><language>eng ; kor</language><subject>HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2011</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20110930&amp;DB=EPODOC&amp;CC=KR&amp;NR=20110107317A$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25564,76547</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20110930&amp;DB=EPODOC&amp;CC=KR&amp;NR=20110107317A$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>YU ALICE</creatorcontrib><creatorcontrib>CHANG YA JEN</creatorcontrib><creatorcontrib>LIN YI LING</creatorcontrib><creatorcontrib>JAN JIA TSRONG</creatorcontrib><creatorcontrib>LIN KUN HSIEN</creatorcontrib><creatorcontrib>HUNG JUNG TUNG</creatorcontrib><creatorcontrib>CHENG Y. S. EDMOND</creatorcontrib><creatorcontrib>WONG CHI HUEY</creatorcontrib><title>ALPHA-GALACTOSYL CERAMIDE ANALOGS AND THEIR USE AS IMMUNOTHERAPIES, ADJUVANTS, AND INTIVIRAL, ANTIBACTERIAL, AND ANTICANCER AGENTS</title><description>The present disclosure relates to synthetic alpha-galactosyl ceramide (α-GalCer) analogs, and their use as immunotherapies. In one aspect. a method of activating a cytokine response in a subject includes administering an effective amount of a compound to a subject, wherein the subject has an adaptive immune system that includes a population of cells, the population including at least one lymphocyte and at least one antigen-presenting cell, and wherein the compound is represented by the structure of formula 1: or a pharmaceutically acceptable salt thereof; forming a complex between the compound and the antigen-presenting cell, wherein the formation of the complex results in the activation of a receptor on the lymphocyte; and activating the lymphocyte to produce the cytokine response.</description><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2011</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNqNjcEOgjAQRLl4MOo_NPEqCZUD56WtsFoKaQuJJ0JMPRklwS_wy13UD_A0Oy8zs8voBbopIS5Ag_C1O2smlIUKpWJgQNeFI5XMlwotax1Rx7CqWlMTstCgcjsG8th2YPx8UhiNxw4t6Nl6zGlZWfxa-UECDL1hUCgqraPFdbhNYfPTVbQ9KC_KOIyPPkzjcAn38OxPdp9wnvAkS3kG6X-pN5AbPQc</recordid><startdate>20110930</startdate><enddate>20110930</enddate><creator>YU ALICE</creator><creator>CHANG YA JEN</creator><creator>LIN YI LING</creator><creator>JAN JIA TSRONG</creator><creator>LIN KUN HSIEN</creator><creator>HUNG JUNG TUNG</creator><creator>CHENG Y. S. EDMOND</creator><creator>WONG CHI HUEY</creator><scope>EVB</scope></search><sort><creationdate>20110930</creationdate><title>ALPHA-GALACTOSYL CERAMIDE ANALOGS AND THEIR USE AS IMMUNOTHERAPIES, ADJUVANTS, AND INTIVIRAL, ANTIBACTERIAL, AND ANTICANCER AGENTS</title><author>YU ALICE ; CHANG YA JEN ; LIN YI LING ; JAN JIA TSRONG ; LIN KUN HSIEN ; HUNG JUNG TUNG ; CHENG Y. S. EDMOND ; WONG CHI HUEY</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_KR20110107317A3</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng ; kor</language><creationdate>2011</creationdate><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>YU ALICE</creatorcontrib><creatorcontrib>CHANG YA JEN</creatorcontrib><creatorcontrib>LIN YI LING</creatorcontrib><creatorcontrib>JAN JIA TSRONG</creatorcontrib><creatorcontrib>LIN KUN HSIEN</creatorcontrib><creatorcontrib>HUNG JUNG TUNG</creatorcontrib><creatorcontrib>CHENG Y. S. EDMOND</creatorcontrib><creatorcontrib>WONG CHI HUEY</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>YU ALICE</au><au>CHANG YA JEN</au><au>LIN YI LING</au><au>JAN JIA TSRONG</au><au>LIN KUN HSIEN</au><au>HUNG JUNG TUNG</au><au>CHENG Y. S. EDMOND</au><au>WONG CHI HUEY</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>ALPHA-GALACTOSYL CERAMIDE ANALOGS AND THEIR USE AS IMMUNOTHERAPIES, ADJUVANTS, AND INTIVIRAL, ANTIBACTERIAL, AND ANTICANCER AGENTS</title><date>2011-09-30</date><risdate>2011</risdate><abstract>The present disclosure relates to synthetic alpha-galactosyl ceramide (α-GalCer) analogs, and their use as immunotherapies. In one aspect. a method of activating a cytokine response in a subject includes administering an effective amount of a compound to a subject, wherein the subject has an adaptive immune system that includes a population of cells, the population including at least one lymphocyte and at least one antigen-presenting cell, and wherein the compound is represented by the structure of formula 1: or a pharmaceutically acceptable salt thereof; forming a complex between the compound and the antigen-presenting cell, wherein the formation of the complex results in the activation of a receptor on the lymphocyte; and activating the lymphocyte to produce the cytokine response.</abstract><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language eng ; kor
recordid cdi_epo_espacenet_KR20110107317A
source esp@cenet
subjects HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
title ALPHA-GALACTOSYL CERAMIDE ANALOGS AND THEIR USE AS IMMUNOTHERAPIES, ADJUVANTS, AND INTIVIRAL, ANTIBACTERIAL, AND ANTICANCER AGENTS
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-05T08%3A48%3A31IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=YU%20ALICE&rft.date=2011-09-30&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EKR20110107317A%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true